Three-year clinical outcome of biodegradable hybrid polymer Orsiro sirolimus-eluting stent and the durable biocompatible polymer Resolute Integrity zotarolimus-eluting stent: A randomized controlled trial.

导出 OA

翻译打印收藏纠错

作者： Soo-Hyun,Kim ^[1] ; Si-Hyuck,Kang ^[1] ; Joo Myung,Lee ^[2] ; Woo-Young,Chung ^[3] ; Jin Joo,Park ^[1] ; Chang-Hwan,Yoon ^[1] ; Jung-Won,Suh ^[1] ; Young-Seok,Cho ^[1] ; Joon-Hyung,Doh ^[4] ; Jin Man,Cho ^[5] ; Jang-Whan,Bae ^[6] ; Tae-Jin,Youn ^[1] ; In-Ho,Chae ^[1]

作者单位： Division of Cardiology, Department of Internal Medicine, College of Medicine, Seoul National University and Cardiovascular Center, Seoul National University Bundang Hospital, Seongnam-si, Gyeonggi-do, Republic of Korea. ^[1] Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. ^[2] Department of Internal Medicine, Boramae Medical Center, Seoul, Republic of Korea. ^[3] Division of Cardiology, Department of Internal Medicine, Inje University Ilsan Paik Hospital, Goyang, Gyeonggi-do, Republic of Korea. ^[4] Division of Cardiology, Department of Internal Medicine, Kyung Hee University Hospital at Gangdong, Seoul, Republic of Korea. ^[5] Department of Internal Medicine, College of Medicine, Chungbuk National University, Cheongju, Republic of Korea. ^[6]

关键词 biodegradable polymer coronary artery disease drug-eluting stents percutaneous coronary intervention